Economic impact of biologic utilization patterns in patients with psoriatic arthritis

The aim of the study is to examine the frequency and costs associated with above-label dosing of biologics in patients with psoriatic arthritis (PsA). MarketScan identified adults with ≥1 International Classification of Diseases, Clinical Modification diagnosis for PsA and ≥1 pharmacy claim for biol...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwartzman, Sergio, Li, Yunfeng, Zhou, Huanxue, Palmer, Jacqueline B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486473/
https://www.ncbi.nlm.nih.gov/pubmed/28474139
http://dx.doi.org/10.1007/s10067-017-3636-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486473/
https://www.ncbi.nlm.nih.gov/pubmed/28474139
http://dx.doi.org/10.1007/s10067-017-3636-3

Ejemplares similares